FATE Therapeutics Inc Form 144 Filed on 20 May 2023

On 20 May 2023, FATE Therapeutics Inc (FATE) filed Form 144 with the SEC. This form is utilized for the sale of restricted and control securities, indicating potential stock sales by insiders or affiliates. The filing is part of regular regulatory requirements, ensuring transparency in equity transactions. Monitoring these filings can provide insight into shareholder sentiment and potential market movements.